Filter Results:
(479)
Show Results For
- All HBS Web (479)
- Faculty Publications (185)
Show Results For
- All HBS Web (479)
- Faculty Publications (185)
- 24 May 2011
- First Look
First Look: May 24
perspective that Porter has taken, often as a result of his specific background and prior research interests. The chapter then turns to extensions of these core concepts in Porter's more recent work. A central focus of this work has been... View Details
Keywords: Sean Silverthorne
- 13 Jul 2020
- Research & Ideas
Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk
As chairman and CEO of the leading vaccine producer in the world, pharmaceutical giant Merck & Co., Ken Frazier has one of the highest-profile positions in global business. But Frazier, who is leading one of the firms on a charge to... View Details
- April 2003 (Revised October 2004)
- Case
Novartis: The Challenge of Success (A)
By: Sandra J. Sucher and Stacy McManus
Preliminary results from Phase 1 clinical trials of a newly developed compound, STI571, showed that 31 out of 31 patients with chronic myelogenous leukemia (CML) had their blood counts return to normal. In the world of oncology, this was unheard of. This was the... View Details
Keywords: Decision Making; Health Testing and Trials; Innovation and Invention; Markets; Distribution; Product Development; Production; Problems and Challenges; Research; Research and Development; Complexity; Pharmaceutical Industry; Pharmaceutical Industry
Sucher, Sandra J., and Stacy McManus. "Novartis: The Challenge of Success (A)." Harvard Business School Case 603-043, April 2003. (Revised October 2004.)
- Web
Academics - Health Care
span the many sectors of the health care industry. During the second-year "elective curriculum" (EC), students may choose courses and field-based research specific to their particular health care interests. Some students also choose to... View Details
- 13 Jul 2023
- News
The Network Effect
between the two companies. In March 2021, Model was a part of the Agios team that finalized the sale of the biotech’s oncology portfolio to international pharmaceutical company Servier. For Agios, the sale was part of a pivot from cancer... View Details
- 09 Oct 2020
- Blog Post
4 Things To Know About the MS/MBA Biotech
myself, did come from a biotechnology company, but there were also people from life sciences consulting firms, research laboratories, medical device companies and larger pharmaceutical companies. This... View Details
- 15 Jul 2013
- Research & Ideas
Five Imperatives for Improving Health Care
Business Administration at HBS and a member of the Forum's faculty steering committee. Other committee members include William W. Chin, Executive Dean for Research at HMS; Richard G. Hamermesh, MBA Class of 1961 Professor of Management... View Details
- 14 Dec 2010
- First Look
First Look: Dec. 14
research on firm entry into new domains by examining heterogeneity in firms' framing and feature-level entry choices. Download the paper: http://www.hbs.edu/research/pdf/11-007.pdf Modularity for Value Appropriation—How to Draw the... View Details
Keywords: Sean Silverthorne
- 01 Oct 2013
- First Look
First Look: October 1
http://www.people.hbs.edu/liyer/BCCI_JEBO_Final_Sept2013.pdf August 2013 Contemporary Accounting Research The Role of Performance Measures in the Intertemporal Decisions of Business Unit Managers By: Bouwens, Jan, Margaret A. Abernethy,... View Details
Keywords: Sean Silverthorne
- 12 Jan 2016
- First Look
January 12, 2016
November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing drug surveillance is the... View Details
Keywords: Carmen Nobel
- 03 Sep 2013
- First Look
First Look: September 3
Research Center: Growing a Joint Research Venture in India Bristol Myers Squibb, a multi-national pharmaceutical company, is seeking to globalize its R&D strategy while... View Details
Keywords: Sean Silverthorne
- 26 Jul 2010
- Research & Ideas
Yes, You Can Raise Prices in a Downturn
Beachwood, Ohio. In this interview the researchers discuss pricing strategy and what ingredients are necessary to convince customers that higher prices are worth the cost. Sean Silverthorne: Who would benefit by learning about your... View Details
- 03 Nov 2015
- First Look
November 3, 2015
https://www.hbs.edu/faculty/Pages/item.aspx?num=50057 November 2015 Negotiation and Conflict Management Research Done but Not Published: The Dissertation Journeys of Roy J. Lewicki and J. Keith Murnighan By: Kopelman, Shirli, Anne L.... View Details
Keywords: Sean Silverthorne
- 18 Dec 2012
- First Look
First Look: December 18
To confirm causation and explore the mechanisms underlying the effects, we replicated the results in a laboratory experiment. We found that individuals working temporarily as part of a research team were more engaged and satisfied with... View Details
Keywords: Carmen Nobel
- 22 Feb 2024
- News
Combat-Tested Cancer Coaching
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Hi, this is Dan Morrell, host of Skydeck. When Kathy Giusti (MBA 1985) was diagnosed with multiple myeloma in 1996, she was overwhelmed. It was the pre-Internet era, with limited available information, but... View Details
- 19 Apr 2010
- Research & Ideas
The History of Beauty
you have a major industry that still has lots to reveal. We asked Jones to discuss his research and his new book. Sean Silverthorne: What inspired your interest in the beauty business and its history? Geoffrey Jones: My initial interest... View Details
- February 2024
- Case
Compass Pathways: Pioneering Psychedelic Treatment
By: Tiona Zuzul, Kisha Lashley and Gamze Yucaoglu
This case follows Compass Pathways, a pioneering company developing treatment for depression based on psilocybin, the compound found in ‘magic mushrooms.’ Psilocybin was a federally illegal substance in the U.S., and a “Schedule I” drug, defined as a drug “with no... View Details
Keywords: Commercialization; Corporate Strategy; Competitive Strategy; Product Launch; Health Testing and Trials; Research and Development; Laws and Statutes; Pharmaceutical Industry; Europe; United States; United Kingdom
Zuzul, Tiona, Kisha Lashley, and Gamze Yucaoglu. "Compass Pathways: Pioneering Psychedelic Treatment." Harvard Business School Case 724-412, February 2024.
- October 1990 (Revised April 1991)
- Case
RU 486 (A)
Describes the factors faced by Roussel UCLAF, a French drug company, in deciding whether and how to market a controversial new drug, RU 486, which is often called "the French abortion pill." Roussel's decision involved its relations with the French government, its... View Details
Keywords: Judgments; Ethics; Product Launch; Negotiation; Outcome or Result; Performance; Business and Government Relations; Pharmaceutical Industry; Pharmaceutical Industry; France; Germany; United States
Badaracco, Joseph L., Jr. "RU 486 (A)." Harvard Business School Case 391-050, October 1990. (Revised April 1991.)
- 18 Nov 2014
- First Look
First Look: November 18
business model and analyzes how his firm evolved into a diversified business group. The research supports prevailing explanations of business groups, which identify the role of institutional voids, government policies, and contact... View Details
Keywords: Sean Silverthorne
- 31 Jan 2014
- News
Body, Heal Thyself
for the development and exclusive use of the mRNA technology to treat cardiovascular, renal, and metabolic diseases as well as cancer. "It is one of the largest-ever initial payments in a pharmaceutical industry licensing deal that does... View Details